MUFG Securities EMEA plc

Broker-Dealer

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1597694 LONDON, X0

Position in REGN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$5,690,426

-$7,546,442 QoQ

Shares Held

9,126

-46.7% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#377

of 1,327 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MUFG Securities EMEA plc holds $54,340,047 across 8 Biotechnology names. REGN ranks #4 (10.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	180,500	$23,957,765
2	VRTX	Vertex Pharmaceuticals Inc / Ma	22,809	$11,329,914
3	RVMD	Revolution Medicines, Inc.	49,043	$9,184,773
4	REGN	Regeneron Pharmaceuticals, Inc. This page	9,126	$5,690,426
5	ALNY	Alnylam Pharmaceuticals, Inc.	6,758	$2,034,360
6	MRNA	Moderna, Inc.	13,822	$967,954
7	INCY	Incyte Corp	6,546	$742,054
8	TECH	BIO-TECHNE Corp	6,126	$432,801

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,690,426	9,126	-46.7%	Shares	Defined	2026-08-12
2026-03-31	$13,236,868	17,132	+314.6%	Shares	Defined	2026-05-11
2025-12-31	$3,189,366	4,132	+111.9%	Shares	Defined	2026-02-10
2025-09-30	$1,096,426	1,950	+535.2%	Shares	Sole	2025-11-14
2025-06-30	$161,175	307	+127.4%	Shares	Sole	2025-10-07
2022-09-30	$92,997	135	0.0%	Shares	Sole	2022-11-09
2022-06-30	$79,802	135	0.0%	Shares	Sole	2022-08-15
2022-03-31	$94,286	135	0.0%	Shares	Sole	2022-05-18
2021-12-31	$85,255	135	0.0%	Shares	Sole	2022-02-11
2021-09-30	$81,699	135	-82.7%	Shares	Sole	2021-11-12
2021-06-30	$435,661	780	-72.9%	Shares	Sole	2021-07-19
2021-03-31	$1,362,643	2,880	+144.1%	Shares	Sole	2021-05-11
2020-12-31	$570,069	1,180	+90.0%	Shares	Sole	2021-02-11
2020-09-30	$347,623	621	-51.5%	Shares	Sole	2020-11-13
2020-03-31	$625,011	1,280	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.